This cardiovascular advantage is an essential factor to consider when selecting diabetes drugs, as it addresses one of the most common complications associated with the condition
A method-of-use patent claiming treatment of disease X with compound Y must satisfy non-obviousness requirements meaning the connection between Y and X must not have been obvious from the prior art at the time of filing
It describes both semaglutide and tirzepatide as having favorable safety profiles when used as directed, with gastrointestinal effects as the most common issue
Wegovy 7/ Saxenda vs
The study, from researchers at Yale University, King's College Hospital in London and the nonprofit Doctors Without Borders, raises more questions about the hefty price tag of the top-selling diabetes treatment and similar drugs for weight loss, which are all part of a new class of treatments called GLP-1s
Future research will focus on three directions: Further exploring effects in humans and conducting clinical trials to verify safety and efficacy in human anti-aging, supporting translational application
